| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-Utility Analysis of Trabecular Bypass Devices Versus Usual Care for Patients With Open-Angle Glaucoma
|
Healey, Paul R.
|
|
|
|
3 |
p. 355-365
|
artikel
|
| 2 |
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy
|
Cortesi, Paolo Angelo
|
|
|
|
3 |
p. 405-416
|
artikel
|
| 3 |
All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe
|
Bouvy, Jacoline C.
|
|
2019
|
|
3 |
p. 419-422
|
artikel
|
| 4 |
All Male Panels and Other Diversity Considerations for ISPOR
|
Devlin, Nancy J.
|
|
2019
|
|
3 |
p. 423-426
|
artikel
|
| 5 |
An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer
|
Ezeofor, Victory ‘Segun
|
|
|
|
3 |
p. 389-403
|
artikel
|
| 6 |
Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
|
Wigfield, Peter
|
|
|
|
3 |
p. 403-418
|
artikel
|
| 7 |
A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use
|
Appukkuttan, Sreevalsa
|
|
|
|
3 |
p. 439-447
|
artikel
|
| 8 |
A Review of Clinical and Economic Evaluations Applied to Psychotropic Therapies Used in the Treatment of Schizophrenia in Argentina
|
González, Gisela Paula
|
|
2017
|
|
3 |
p. 233-239
|
artikel
|
| 9 |
A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung Cancer
|
Qiao, Nan
|
|
|
|
3 |
p. 365-383
|
artikel
|
| 10 |
A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
|
Walton, M. J.
|
|
2019
|
|
3 |
p. 403-410
|
artikel
|
| 11 |
Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) Amyloidosis
|
McCausland, Kristen L.
|
|
2019
|
|
3 |
p. 367-375
|
artikel
|
| 12 |
Authors’ Reply to Salamanca: “Systematic Review of Economic Evaluations in Primary Open Angle Glaucoma: Decision Analytic Modeling Insights”
|
Bartelt-Hofer, Jose
|
|
|
|
3 |
p. 551-552
|
artikel
|
| 13 |
Benefit–Cost Analysis of the Danish Sun Safety Campaign 2007–2015: Cost Savings from Sunburn and Sunbed Use Reduction and Derived Skin Cancer Reductions 2007–2040 in the Danish Population
|
Køster, Brian
|
|
|
|
3 |
p. 419-425
|
artikel
|
| 14 |
Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective
|
Blissett, Deirdre B.
|
|
|
|
3 |
p. 475-489
|
artikel
|
| 15 |
Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
|
Schreurs, Rachel H. P.
|
|
|
|
3 |
p. 479-491
|
artikel
|
| 16 |
Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US
|
Edelman, Steve
|
|
|
|
3 |
p. 519-528
|
artikel
|
| 17 |
Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
|
Vogler, Sabine
|
|
2017
|
|
3 |
p. 145-147
|
artikel
|
| 18 |
Comment on: “Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights”
|
Salamanca, Omar
|
|
|
|
3 |
p. 549-550
|
artikel
|
| 19 |
Community Distribution of Naloxone: A Systematic Review of Economic Evaluations
|
Cherrier, Nelda
|
|
|
|
3 |
p. 329-342
|
artikel
|
| 20 |
Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis
|
Kim, Hansoo
|
|
|
|
3 |
p. 459-467
|
artikel
|
| 21 |
Correction to: Benefit–Cost Analysis of the Danish Sun Safety Campaign 2007–2015: Cost Savings from Sunburn and Sunbed Use Reduction and Derived Skin Cancer Reductions 2007–2040 in the Danish Population
|
Køster, Brian
|
|
|
|
3 |
p. 553-554
|
artikel
|
| 22 |
Correction to: Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
|
Shen, Jing
|
|
2019
|
|
3 |
p. 427
|
artikel
|
| 23 |
Correction to: Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications
|
Okafor, Charles Ebuka
|
|
|
|
3 |
p. 559
|
artikel
|
| 24 |
Cost Analysis of a Digital Health Care Model in Sweden
|
Ekman, Björn
|
|
2017
|
|
3 |
p. 347-354
|
artikel
|
| 25 |
Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial
|
Yan, Charles
|
|
|
|
3 |
p. 493-505
|
artikel
|
| 26 |
Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain
|
Alonso Torres, A. M.
|
|
|
|
3 |
p. 431-441
|
artikel
|
| 27 |
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
|
Oyagüez, Itziar
|
|
|
|
3 |
p. 485-497
|
artikel
|
| 28 |
Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium
|
Rinciog, C.
|
|
|
|
3 |
p. 449-458
|
artikel
|
| 29 |
Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy
|
Bailey, Cate
|
|
|
|
3 |
p. 499-510
|
artikel
|
| 30 |
Cost-effectiveness of a Province-wide Quality Improvement Initiative for Reducing Potentially Inappropriate Use of Antipsychotics in Long-Term Care in British Columbia, Canada
|
Khowaja, Asif Raza
|
|
|
|
3 |
p. 491-504
|
artikel
|
| 31 |
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
|
Bullement, Ash
|
|
2019
|
|
3 |
p. 377-390
|
artikel
|
| 32 |
Cost-Effectiveness of Constraint-Induced Movement Therapy Implementation in Neurorehabilitation: The ACTIveARM Project
|
Christie, Lauren J.
|
|
|
|
3 |
p. 437-450
|
artikel
|
| 33 |
Cost Effectiveness of Digital Interventions for Generalised Anxiety Disorder: A Model-Based Analysis
|
Jankovic, Dina
|
|
|
|
3 |
p. 377-388
|
artikel
|
| 34 |
Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial
|
Alshreef, Abualbishr
|
|
2017
|
|
3 |
p. 175-184
|
artikel
|
| 35 |
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States
|
Sepassi, Aryana
|
|
|
|
3 |
p. 393-404
|
artikel
|
| 36 |
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
|
Hollingworth, William
|
|
|
|
3 |
p. 427-438
|
artikel
|
| 37 |
Cost Effectiveness of Stapled Haemorrhoidopexy and Traditional Excisional Surgery for the Treatment of Haemorrhoidal Disease
|
Kilonzo, Mary M.
|
|
2017
|
|
3 |
p. 271-280
|
artikel
|
| 38 |
Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study
|
Darsonval, Astrid
|
|
2017
|
|
3 |
p. 223-229
|
artikel
|
| 39 |
Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib
|
Mahlich, Jörg
|
|
2017
|
|
3 |
p. 195-202
|
artikel
|
| 40 |
Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications
|
Prinja, Shankar
|
|
2019
|
|
3 |
p. 391-402
|
artikel
|
| 41 |
Cost Savings of Mother’s Own Milk for Very Low Birth Weight Infants in the Neonatal Intensive Care Unit
|
Johnson, Tricia J.
|
|
|
|
3 |
p. 451-460
|
artikel
|
| 42 |
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials
|
Porter, Joshua K.
|
|
2018
|
|
3 |
p. 411-417
|
artikel
|
| 43 |
Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
|
Whitehurst, David G. T.
|
|
2018
|
|
3 |
p. 225-231
|
artikel
|
| 44 |
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology
|
Jayasundara, Kavisha
|
|
2017
|
|
3 |
p. 167-173
|
artikel
|
| 45 |
DyeVert™ PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost–Utility Analysis
|
Javanbakht, Mehdi
|
|
|
|
3 |
p. 459-472
|
artikel
|
| 46 |
Economic Analysis of Transforaminal Lumbar Interbody Fusion Surgery Utilizing a Curved Bone Removal Device
|
Peloza, John H.
|
|
|
|
3 |
p. 519-531
|
artikel
|
| 47 |
Economic Evaluation Comparing Virtual Reality with Child Life Programming for Non-sedated Pediatric Medical Imaging: A Cost-Consequence Analysis
|
Jacob, John
|
|
|
|
3 |
p. 417-429
|
artikel
|
| 48 |
Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan
|
Moriwaki, Kensuke
|
|
|
|
3 |
p. 437-447
|
artikel
|
| 49 |
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
|
Quon, Peter L.
|
|
2019
|
|
3 |
p. 321-331
|
artikel
|
| 50 |
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
|
Dymond, Amy
|
|
|
|
3 |
p. 443-454
|
artikel
|
| 51 |
Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers
|
Di Tanna, Gian Luca
|
|
|
|
3 |
p. 397-401
|
artikel
|
| 52 |
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
|
Entrenas Costa, Luis Manuel
|
|
2019
|
|
3 |
p. 333-342
|
artikel
|
| 53 |
Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement
|
Quinlan, Taryn A. G.
|
|
|
|
3 |
p. 449-458
|
artikel
|
| 54 |
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
|
Cooper, Owen Alan Edwards
|
|
|
|
3 |
p. 469-477
|
artikel
|
| 55 |
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
|
Estrada, Vicente
|
|
|
|
3 |
p. 415-424
|
artikel
|
| 56 |
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Fleeman, Nigel
|
|
2019
|
|
3 |
p. 293-302
|
artikel
|
| 57 |
Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy Group
|
Keeping, Stuart
|
|
2019
|
|
3 |
p. 343-350
|
artikel
|
| 58 |
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications
|
Ezenduka, Charles C.
|
|
2017
|
|
3 |
p. 185-194
|
artikel
|
| 59 |
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
|
Verhoek, Andre
|
|
|
|
3 |
p. 455-467
|
artikel
|
| 60 |
Evaluation of Health Status of Type 2 Diabetes Outpatients Receiving Care in a Tertiary Hospital in Nigeria
|
Adibe, Maxwell Ogochukwu
|
|
2017
|
|
3 |
p. 337-345
|
artikel
|
| 61 |
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing
|
Vogler, Sabine
|
|
2019
|
|
3 |
p. 303-309
|
artikel
|
| 62 |
Examining the Association between Polish Migrant Status and Health Preferences Using a Novel Application of a Smaller Design EQ-5D-5L Valuation Study
|
Kelleher, Dan
|
|
|
|
3 |
p. 425-435
|
artikel
|
| 63 |
Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
|
Landfeldt, Erik
|
|
2018
|
|
3 |
p. 279-280
|
artikel
|
| 64 |
Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand
|
Tanvejsilp, Pimwara
|
|
2017
|
|
3 |
p. 297-308
|
artikel
|
| 65 |
Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review
|
Magni, Tiziana
|
|
|
|
3 |
p. 359-371
|
artikel
|
| 66 |
Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
|
Howell, Timothy A.
|
|
|
|
3 |
p. 367-376
|
artikel
|
| 67 |
Health System Efficiency: A Fragmented Picture Based on OECD Data
|
Behr, Andreas
|
|
2017
|
|
3 |
p. 203-221
|
artikel
|
| 68 |
High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?
|
Greiner, Wolfgang
|
|
|
|
3 |
p. 385-396
|
artikel
|
| 69 |
Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?
|
Garattini, Livio
|
|
2018
|
|
3 |
p. 221-224
|
artikel
|
| 70 |
HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?
|
Seo, Mikyung Kelly
|
|
|
|
3 |
p. 529-539
|
artikel
|
| 71 |
Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067
|
Shao, Taihang
|
|
|
|
3 |
p. 383-392
|
artikel
|
| 72 |
Impact of Fluid Choice in Systemic Inflammatory Response Syndrome Patients on Hospital Cost Savings
|
Laplante, Suzanne
|
|
2017
|
|
3 |
p. 325-335
|
artikel
|
| 73 |
Impact of Letermovir Use for Cytomegalovirus Prophylaxis on Re-Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of a Phase III Randomized Clinical Trial
|
Golan, Yoav
|
|
|
|
3 |
p. 469-473
|
artikel
|
| 74 |
Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications
|
Okafor, Charles Ebuka
|
|
|
|
3 |
p. 545-557
|
artikel
|
| 75 |
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
|
Eliasson, Björn
|
|
|
|
3 |
p. 343-354
|
artikel
|
| 76 |
Metabolic Acidosis in Preterm Infants is Associated with a Longer Length of Stay in the Neonatal Intensive Care Unit
|
Paul, Marika
|
|
|
|
3 |
p. 541-547
|
artikel
|
| 77 |
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review
|
Kolovos, Spyros
|
|
2017
|
|
3 |
p. 149-165
|
artikel
|
| 78 |
National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison
|
Sharma, Deepshikha
|
|
|
|
3 |
p. 349-364
|
artikel
|
| 79 |
Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology
|
Ball, Graeme
|
|
|
|
3 |
p. 397-410
|
artikel
|
| 80 |
Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand
|
Tanvejsilp, Pimwara
|
|
2017
|
|
3 |
p. 281-296
|
artikel
|
| 81 |
Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data
|
Schmitz, Susanne
|
|
|
|
3 |
p. 405-414
|
artikel
|
| 82 |
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
|
Brod, Meryl
|
|
|
|
3 |
p. 505-518
|
artikel
|
| 83 |
Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study
|
Sebastian, Shaji
|
|
2019
|
|
3 |
p. 359-365
|
artikel
|
| 84 |
Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
|
O’Mahony, James F.
|
|
|
|
3 |
p. 339-348
|
artikel
|
| 85 |
Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: An Economic Evaluation of TEST-BP, A Randomised Controlled Trial
|
Kim, Lois G.
|
|
|
|
3 |
p. 511-517
|
artikel
|
| 86 |
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort Study
|
Melzer Cohen, Cheli
|
|
|
|
3 |
p. 533-544
|
artikel
|
| 87 |
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries
|
Fontrier, Anna-Maria
|
|
|
|
3 |
p. 315-328
|
artikel
|
| 88 |
Stage-Related Cost of Treatment of Bladder Cancer in Brazil
|
Korkes, Fernando
|
|
|
|
3 |
p. 461-468
|
artikel
|
| 89 |
State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling Approach
|
Garbinsky, Diana
|
|
|
|
3 |
p. 411-423
|
artikel
|
| 90 |
The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
|
Pennington, Becky
|
|
2018
|
|
3 |
p. 241-253
|
artikel
|
| 91 |
The Cost Effectiveness of Stockpiling Drugs, Vaccines and Other Health Resources for Pandemic Preparedness
|
Plans-Rubió, Pedro
|
|
|
|
3 |
p. 393-395
|
artikel
|
| 92 |
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency
|
Jommi, Claudio
|
|
|
|
3 |
p. 373-381
|
artikel
|
| 93 |
The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease
|
Tran, Dat T.
|
|
|
|
3 |
p. 425-435
|
artikel
|
| 94 |
The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study
|
Hannouf, Malek B.
|
|
2017
|
|
3 |
p. 255-270
|
artikel
|
| 95 |
The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
|
Lee, Dawn
|
|
2018
|
|
3 |
p. 351-358
|
artikel
|
| 96 |
The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method
|
Moradi, Najme
|
|
2019
|
|
3 |
p. 311-319
|
artikel
|
| 97 |
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Houten, Rachel
|
|
|
|
3 |
p. 345-358
|
artikel
|
| 98 |
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
|
Rifkin, Robert M.
|
|
|
|
3 |
p. 473-483
|
artikel
|
| 99 |
Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility
|
Skedgel, Chris
|
|
|
|
3 |
p. 337-344
|
artikel
|
| 100 |
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK
|
Yang, Yaling
|
|
2018
|
|
3 |
p. 281-291
|
artikel
|
| 101 |
Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis
|
Michaud, Tzeyu L.
|
|
2017
|
|
3 |
p. 309-323
|
artikel
|
Tijdschrift beschrijving